Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Evaluation of Red Blood Cell Distribution Width (RDW) in Severe and Critical COVID-19 Patients Monitored in the Intensive Care Unit

NCT07244731 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.

NCT NCT07244731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07244731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Evaluation of Red Blood Cell Distribution Width (RDW) in Severe and Critical COVID-19 Patients Monitored in the Intensive Care Unit
Lead sponsor
Ankara University
Phase
Observational
Overall status
Completed
Start date
September 1, 2024
Completion date
June 1, 2025
Enrollment
146 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid - 19, icu, prognosis